🇺🇸 FDA
Patent

US 8076304

Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions

granted A61PA61P35/00

Quick answer

US patent 8076304 (Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions) held by The Regents of the University of Colorado expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P35/00